| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ciprofloxacin | FAERS: 18 | US FAERS | |
| 2 | Acyclovir | FAERS: 11 | US FAERS | |
| 3 | Doxycycline | FAERS: 9 | US FAERS | |
| 4 | Ascorbic Acid | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 5 | Levofloxacin | FAERS: 5 | US FAERS | |
| 6 | Methotrexate | FAERS: 3 | US FAERS | |
| 7 | Amoxicillin | FAERS: 1 | US FAERS | |
| 8 | Atazanavir Sulfate | FAERS: 1 | US FAERS | |
| 9 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 10 | Doxycycline | FAERS: 1 | US FAERS | |
| 11 | Orlistat | FAERS: 1 | US FAERS | |
| 12 | Sofosbuvir | FAERS: 1 | US FAERS | |
| 13 | Trimethoprim, Sulfamethoxazole Drug Combination | FAERS: 1 | US FAERS | |
| 14 | pazopanib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.